Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 6, 1998, Pages 758-762

  Vuillaume, I ^a   Vermersch, P ^a   Destee A ^a   Petit, H ^a   Sablonniere B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Clinical features; Genotype; Huntington's disease; Polymorphisms

Indexed keywords

GLUTAMIC ACID;

ADULT; ARTICLE; CLINICAL FEATURE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; NORMAL HUMAN; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

EID: 0031747231     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.6.758     Document Type: Article

References (33)

1. Hayden MR. Huntington's chorea. New-York: Springer Verlag 1981.
2. Harper PS. Huntington's disease. London: Saunders 1991.
3. Folstein JE. Huntington's disease: a disorder of families. Baltimore: Johns Hopkins University Press, 1989.
4. Di Maio L, Squitieri F, Napolitano G, et al. Onset symptoms in 510 patients with Huntington's disease. J Med Genet 1993;30:289-92.
5. Claes S, Van Zand K, Legius E, et al. Correlations between triplet repeat expansion and clinical features in Huntington's disease. Arch Neurol 1995;52:749-53.
6. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306:234-8.
7. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
8. Kremer B, Goldberg P, Andrew SE, et al. A worldwide study of the Huntington's disease mutation. N Engl J Med 1994; 20:1401-6.
9. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleptide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 1993;4:398-403.
10. Rubinsztein DC, Barton DE, Davison BCC, et al. Analysis of the huntingtin gene reveals a trinucleotide length polymorphism in the region of the gene that contains two CCG rich stretches and a correlation between decrease age of onset of Huntington's disease and CAG repeat number. Hum Mol Genet 1993;10:1713-5.
11. Andrew SE, Goldberg YP, Theilmann J, et al. A CCG polymorphism adjacent to the CAG repeat in Huntington's disease gene: implications for diagnostic accuracy and predictive testing. Hum Mol Genet 1994;3:65-67.
12. Barron LH, Rae A, Holloway S, et al. A single allele from the polymorphic CCG-rich sequence immediately 3′ to the unstable CAG trinucleotide in the IT-15 cDNA shows almost complete disequilibrium with HD chromosomes in the Scottish population. Hum Mol Genet 1994;3: 173-5.
13. Novelletto A, Persichetti F, Sabbadini G, et al. Polymorphism analysis of the Huntington gene in Italian families affected with Huntington's disease. Hum Mol Genet 1994; 3:1129-32.
14. Squitieri F, Andrew SE, Goldberg YP, et al. DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum Mol Genet 1994; 3:2103-14.
15. Almqvist A, Spence N, Nichol K, et al. Ancestral differences in the distribution of the Δ2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington's disease. Hum Mol Genet 1995;4:207-14.
16. Duyao M, Ambrose C, Myers R, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 1993;4:387-92.
17. Snell RG, MacMillan JC, Cheadle JP, et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 1993;4:393-7.
18. Stine O.C, Pleasant N, Franz ML, et al. Correlation between the onset age of Huntington's disease and the length of the trinucleotide repeat in IT-15. Hum Mol Genet 1993;2: 1547-9.
19. MacMillan JC, Snell RG, Tyler A, et al. Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet 1993;342:954-8.
20. Brinkman RR, Mezei MM, Theilmann J, et al. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997;60:1202-10.
21. Weigell-Weber M, Schmidt W, Spiegel R. Psychiatric symptoms and CAG expansion in Huntington's disease. Am J Med Genet 1996;67:53-7.
22. Zappacosta B, Monza D, Meoni C, et al. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease. Arch Neurol 1996;53:493-7.
23. Warner JP, Barren LH, Brock DJH. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 1993;7:235-9.
24. Ambrose CM, Duyao MP, Barnes G, et al. Structure and expression of Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet 1994;20:27-38.
25. Lucotte G, Gerard N, Roubertoux P, et al. Relationships of the 2642 deletion polymorphism (Δ2642) in the Huntington gene with the CAG repeat expansion length and age at onset of the disease. Genet Couns 1996;7:297-302.
26. Telenius H, Kremer HPH, Theilmann J, et al. Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum Mol Genet 1993;10:1535-40.
27. Farrer LA, Cupples LA, Wiater P, et al. The normal HD allele, or a closely linked gene influences age at onset of Huntington's disease. Am J Hum Genet 1993;53:125-30.
28. Farrer LA, Conneally PM. A genetic model for age at onset in Huntington's disease. Am J Hum Genet 1985;37:350-7.
29. Farrer LA, Cupples LA, Kiely DK, et al. Inverse relationship between age at onset of Huntington's disease and paternal age suggests involvement of genetic imprinting. Am J Hum Genet 1992;50:528-35.
30. Farrer LA, Conneally PM, Yu PI. The natural history of Huntington's disease: possible role of "aging genes". Am J Med Genet 1984;18:115-23.
31. Illarioshkin SN, Igarashi S, Onodera O, et al. Trinucleotide repeat length and rate of progression of Huntington's disease. Ann Neurol 1994;36:630-5.
32. Roos RAC, Hermans J, Vegter-van der Vlis M, et al. Duration of illness in Huntington's disease is not related to age at onset. J Neurol Neurosurg Psychiatry 1993;56:98-100.
33. Brandt J, Bylsma FW, Gross R, et al. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 1996;46:527-31.